Gilead Sciences (GILD)

Net Receivables

$5.06B

Quarterly · Period ending: · USD

GILD logo

GILD Net Receivables

Latest reported$5.06B
GILD Quarterly Net Receivables ($0.00 → $5.06B)
High-resolution chart · PNG

GILD net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
5,055,000,000
4,741,000,000
4,913,000,000
5,095,000,000
4,781,000,000
4,388,000,000
4,420,000,000
4,587,000,000
4,663,000,000
4,669,000,000
4,660,000,000
4,790,000,000
4,229,000,000
4,162,000,000
4,777,000,000
4,354,000,000
4,118,000,000
3,787,000,000
4,493,000,000
4,566,000,000
4,149,000,000
3,925,000,000
4,892,000,000
3,913,000,000
3,194,000,000
3,907,000,000
3,582,000,000
3,315,000,000
3,396,000,000
3,283,000,000
3,327,000,000
3,465,000,000
3,541,000,000
3,775,000,000
3,851,000,000
4,122,000,000
4,478,000,000
4,034,000,000
4,514,000,000
5,075,000,000
5,752,000,000
6,163,000,000
5,854,000,000
6,105,000,000
5,331,000,000
4,835,000,000
4,635,000,000
2,850,367,000
3,436,711,000
3,236,195,000
2,182,000,000
1,971,926,000
1,895,913,000
1,945,189,000
1,751,388,000
1,766,091,000
1,702,818,000
2,163,659,000
1,951,167,000
1,867,092,000
1,938,645,000
1,801,212,000
1,621,966,000
1,670,405,000
1,482,900,000
1,491,332,000
1,389,534,000
1,339,165,000
1,242,899,000
1,068,000,000
1,023,397,000
1,047,205,000
1,021,369,000
979,802,000
795,127,000
803,628,000
734,512,000
692,066,000
609,320,000
585,050,000
489,319,000
433,633,000
396,125,000
400,623,000
371,984,000
385,444,000
371,245,000
304,298,000
277,305,000
257,491,000
235,217,000
201,056,000
200,306,000
145,980,000
175,036,000
114,062,000
101,462,000
76,935,000
74,228,000
59,402,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.